Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome-cell interactions

Journal of Biological Chemistry

Volumn 291, Issue 4, 2016, Pages 1652-1663

  Purushothaman, Anurag ^a,c   Bandari, Shyam Kumar ^a   Liu, Jian ^d   Mobley, James A ^b   Brown, Elizabeth A ^a,c   Sanderson, Ralph D ^a,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BINS; CELL CULTURE; CELL MEMBRANES; CELLS; CROSSTALK; CYTOLOGY; ENDOTHELIAL CELLS; GENE EXPRESSION; LIGANDS; POLYSACCHARIDES; SULFUR COMPOUNDS; TUMORS;

CELL INTERACTION; DOWNSTREAM TARGET; FIBRONECTIN BINDINGS; FUNDAMENTAL MECHANISMS; HEPARIN BINDING DOMAINS; MARROW STROMAL CELL; MYELOMA CELL LINE; TUMOR MICROENVIRONMENTS;

CELL SIGNALING;

FIBRONECTIN; HEPARAN SULFATE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; RONEPARSTAT; DKK1 PROTEIN, HUMAN; GELATINASE B; HEPARIN; SIGNAL PEPTIDE;

ARTICLE; BINDING AFFINITY; CANCER GROWTH; CELL GROWTH; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DKK1 GENE; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME DEGRADATION; EXOSOME; GENE; GENE TARGETING; HUMAN; HUMAN CELL; MMP 9 GENE; MYELOMA; MYELOMA CELL; PHARMACOLOGICAL BLOCKING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; STROMA CELL; TARGET CELL; CELL COMMUNICATION; CYTOLOGY; GENETICS; METABOLISM; MULTIPLE MYELOMA; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL COMMUNICATION; CELL LINE, TUMOR; ENDOTHELIAL CELLS; EXOSOMES; FIBRONECTINS; HEPARIN; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASE 9; MULTIPLE MYELOMA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 84958954284     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.686295     Document Type: Article

References (42)

1. Szalat, R., and Munshi, N. C. (2015) Genomic heterogeneity in multiple myeloma. Curr. Opin. Genet. Dev. 30, 56-65
2. Witwer, K. W., Buzas, E. I., Bemis, L. T., Bora, A., Lasser, C., Lotvall, J., Nolte-'t Hoen, E. N., Piper, M. G., Sivaraman, S., Skog, J., Thery, C., Wauben, M. H., and Hochberg, F. (2013) Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracell. Vesicles 2, 10.3402/jev.v3402i3400.20360
3. Peinado, H., Lavotshkin, S., and Lyden, D. (2011) The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin. Cancer Biol. 21, 139-146
4. Peinado, H., Aleɥković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C., Nitadori-Hoshino, A., Hoffman, C., Badal, K., Garcia, B. A., Callahan, M. K., Yuan, J., Martins, V. R., Skog, J., Kaplan, R. N., Brady, M. S., Wolchok, J. D., Chapman, P. B., Kang, Y., Bromberg, J., and Lyden, D. (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891
5. Zhang, H. G., and Grizzle, W. E. (2014) Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions. Am. J. Pathol. 184, 28-41
6. Kharaziha, P., Ceder, S., Li, Q., and Panaretakis, T. (2012) Tumor cellderived exosomes: a message in a bottle. Biochim. Biophys. Acta 1826, 103-111
7. Raimondi, L., De Luca, A., Amodio, N., Manno, M., Raccosta, S., Taverna, S., Bellavia, D., Naselli, F., Fontana, S., Schillaci, O., Giardino, R., Fini, M., Tassone, P., Santoro, A., De Leo, G., Giavaresi, G., and Alessandro, R. (2015) Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation. Oncotarget 6, 13772-13789
8. Umezu, T., Tadokoro, H., Azuma, K., Yoshizawa, S., Ohyashiki, K., and Ohyashiki, J. H. (2014) Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood 124, 3748-3757
9. Thompson, C. A., Purushothaman, A., Ramani, V. C., Vlodavsky, I., and Sanderson, R. D. (2013) Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J. Biol. Chem. 288, 10093-10099
10. Sarrazin, S., Lamanna, W. C., and Esko, J. D. (2011) Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 3, a004952
11. Atai, N. A., Balaj, L., van Veen, H., Breakefield, X. O., Jarzyna, P. A., Van Noorden, C. J., Skog, J., and Maguire, C. A. (2013) Heparin blocks transfer of extracellular vesicles between donor and recipient cells. J. Neurooncol. 115, 343-351
12. Christianson, H. C., and Belting, M. (2013) Heparan sulfate proteoglycan as a cell-surface endocytosis receptor. Matrix Biol. 35, 51-55
13. Christianson, H. C., Svensson, K. J., van Kuppevelt, T. H., Li, J. P., and Belting, M. (2013) Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc. Natl. Acad. Sci. U.S.A. 110, 17380-17385
14. Di Noto, G., Chiarini, M., Paolini, L., Mazzoldi, E. L., Giustini, V., Radeghieri, A., Caimi, L., and Ricotta, D. (2014) Immunoglobulin free light chains and GAGs mediate multiple myeloma extracellular vesicles uptake and secondary NFκB nuclear translocation. Front. Immunol. 5, 517
15. Carpentier, M., Denys, A., Allain, F., and Vergoten, G. (2014) Molecular docking of heparin oligosaccharides with Hep-II heparin-binding domain of fibronectin reveals an interplay between the different positions of sulfate groups. Glycoconj. J. 31, 161-169
16. Tumova, S., Woods, A., and Couchman, J. R. (2000) Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences. J. Biol. Chem. 275, 9410-9417
17. Woods, A., Longley, R. L., Tumova, S., and Couchman, J. R. (2000) Syndecan- 4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Arch. Biochem. Biophys. 374, 66-72
18. Dalton, B. A., McFarland, C. D., Underwood, P. A., and Steele, J. G. (1995) Role of the heparin binding domain of fibronectin in attachment and spreading of human bone-derived cells. J. Cell Sci. 108, 2083-2092
19. Børset, M., Hjertner, O., Yaccoby, S., Epstein, J., and Sanderson, R. D. (2000) Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. Blood 96, 2528-2536
20. Purushothaman, A., Chen, L., Yang, Y., and Sanderson, R. D. (2008) Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma. J. Biol. Chem. 283, 32628-32636
21. Purushothaman, A., and Toole, B. P. (2014) Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization. J. Biol. Chem. 289, 5499-5509
22. Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M. V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., Landgren, O., Paiva, B., Dispenzieri, A., Weiss, B., LeLeu, X., Zweegman, S., Lonial, S., Rosinol, L., Zamagni, E., Jagannath, S., Sezer, O., Kristinsson, S. Y., Caers, J., Usmani, S. Z., Lahuerta, J. J., Johnsen, H. E., Beksac, M., Cavo, M., Goldschmidt, H., Terpos, E., Kyle, R. A., Anderson, K. C., Durie, B. G., and Miguel, J. F. (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15, e538-e548
23. Meares, G. P., Liu, Y., Rajbhandari, R., Qin, H., Nozell, S. E., Mobley, J. A., Corbett, J. A., and Benveniste, E. N. (2014) PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation. Mol. Cell Biol. 34, 3911-3925
24. Ritchie, J. P., Ramani, V. C., Ren, Y., Naggi, A., Torri, G., Casu, B., Penco, S., Pisano, C., Carminati, P., Tortoreto, M., Zunino, F., Vlodavsky, I., Sanderson, R. D., and Yang, Y. (2011) SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/ syndecan-1 axis. Clin. Cancer Res. 17, 1382-1393
25. Liu, J., and Linhardt, R. J. (2014) Chemoenzymatic synthesis of heparan sulfate and heparin. Nat. Prod. Rep. 31, 1676-1685
26. Kelly, T., Miao, H. Q., Yang, Y., Navarro, E., Kussie, P., Huang, Y., MacLeod, V., Casciano, J., Joseph, L., Zhan, F., Zangari, M., Barlogie, B., Shaughnessy, J., and Sanderson, R. D. (2003) High heparanase activity in multiple myeloma is associated with elevated microvessel density. Cancer Res. 63, 8749-8756
27. Purushothaman, A., Uyama, T., Kobayashi, F., Yamada, S., Sugahara, K., Rapraeger, A. C., and Sanderson, R. D. (2010) Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. Blood 115, 2449-2457
28. Yang, Y., Macleod, V., Bendre, M., Huang, Y., Theus, A. M., Miao, H. Q., Kussie, P., Yaccoby, S., Epstein, J., Suva, L. J., Kelly, T., and Sanderson, R. D. (2005) Heparanase promotes the spontaneous metastasis of myeloma cells to bone. Blood 105, 1303-1309
29. Yang, Y., Ren, Y., Ramani, V. C., Nan, L., Suva, L. J., and Sanderson, R. D. (2010) Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL. Cancer Res. 70, 8329-8338
30. Underwood, P. A., Dalton, B. A., Steele, J. G., Bennett, F. A., and Strike, P. (1992) Anti-fibronectin antibodies that modify heparin binding and cell adhesion: evidence for a new cell binding site in the heparin binding region. J. Cell Sci. 102, 833-845
31. Hubbard, B., Buczek-Thomas, J. A., Nugent, M. A., and Smith, M. L. (2014) Heparin-dependent regulation of fibronectin matrix conformation. Matrix Biol. 34, 124-131
32. Bayer-Garner, I. B., Sanderson, R. D., Dhodapkar, M. V., Owens, R. B., and Wilson, C. S. (2001) Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions. Mod. Pathol. 14, 1052-1058
33. Mu, W., Rana, S., and Zöller, M. (2013) Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia 15, 875-887
34. Balaj, L., Atai, N. A., Chen, W., Mu, D., Tannous, B. A., Breakefield, X. O., Skog, J., and Maguire, C. A. (2015) Heparin affinity purification of extracellular vesicles. Sci. Rep. 5, 10266
35. Marimpietri, D., Petretto, A., Raffaghello, L., Pezzolo, A., Gagliani, C., Tacchetti, C., Mauri, P., Melioli, G., and Pistoia, V. (2013) Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression. PLoS One 8, e75054
36. Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., Reissfelder, C., Pilarsky, C., Fraga, M. F., Piwnica-Worms, D., and Kalluri, R. (2015) Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523, 177-182
37. Atay, S., Gercel-Taylor, C., and Taylor, D. D. (2011) Human trophoblastderived exosomal fibronectin induces pro-inflammatory IL-1beta production by macrophages. Am. J. Reprod. Immunol. 66, 259-269
38. Sung, B. H., Ketova, T., Hoshino, D., Zijlstra, A., and Weaver, A. M. (2015) Directional cell movement through tissues is controlled by exosome secretion. Nat. Commun. 6, 7164
39. Deng, Z., Cheng, Z., Xiang, X., Yan, J., Zhuang, X., Liu, C., Jiang, H., Ju, S., Zhang, L., Grizzle, W., Mobley, J., Roman, J., Miller, D., and Zhang, H. G. (2012) Tumor cell cross talk with tumor-associated leukocytes leads to induction of tumor exosomal fibronectin and promotes tumor progression. Am. J. Pathol. 180, 390-398
40. Raposo, G., and Stoorvogel, W. (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373-383
41. Baietti, M. F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A., Ivarsson, Y., Depoortere, F., Coomans, C., Vermeiren, E., Zimmermann, P., and David, G. (2012) Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol. 14, 677-685
42. Roucourt, B., Meeussen, S., Bao, J., Zimmermann, P., and David, G. (2015) Heparanase activates the syndecan-syntenin-ALIX exosome pathway. Cell Res. 25, 412-428